Pyxis Oncology appoints Jitendra Wadhane as Chief Accounting Officer

Pyxis Oncology, Inc.

Mr. Wadhane appointed CAO and Principal Accounting Officer effective August 3, 2022.
He previously served as SVP of Finance and Corporate Controller since August 2021.
Prior roles include Head of SEC Reporting at Immunovant and Senior Manager at EY.
He is a CPA with a Bachelor's from University of Mumbai and Chartered Accountancy from ICAI.
No family relationships or arrangements with other directors or officers.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Jitendra Wadhane

Chief Accounting Officer

PYXS · Pyxis Oncology, Inc.

Effective: 2022-08-03
Filed: August 9, 2022, 7:59 PM ET

On August 3, 2022, Jitendra Wadhane, age 42, was appointed as Chief Accounting Officer and to serve as Principal Accounting Officer of Pyxis Oncology, Inc. (the “Company”).

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Jitendra Wadhane was appointed as Chief Accounting Officer at Pyxis Oncology, Inc..

Action: appointed
Role: Chief Accounting Officer

Exact text from the filing

On August 3, 2022, Jitendra Wadhane, age 42, was appointed as Chief Accounting Officer and to serve as Principal Accounting Officer of Pyxis Oncology, Inc. (the “Company”).

View on SEC.gov

Pyxis Oncology, Inc. filing history →

Source: SEC EDGAR

accession 0000950170-22-016063

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.